William J. Link, PhD, a director at Tarsus Pharmaceuticals ($TARS), made six open market sales of company shares over the last year, totaling about $3.4 million. His latest sale occurred on December 15, 2025. These transactions rank 2,488th among roughly 11,700 individual insiders by sale value, trailing the average of $8.6 million per seller and 6.4 transactions. Link recorded no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | S | Common Stock | 493 | $69.75 | 116,332.0000 | 42,607,717 | 0.42% | 0.00% |
| March 16, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | S | Common Stock | 8378 | $69.03 | 116,825.0000 | 42,607,717 | 6.69% | 0.02% |
| March 16, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | S | Common Stock | 3629 | $68.09 | 125,203.0000 | 42,607,717 | 2.82% | 0.01% |
| Dec. 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | S | Common Stock | 1148 | $82.39 | 128,832.0000 | 42,607,717 | 0.88% | 0.00% |
| Dec. 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | S | Common Stock | 6306 | $81.75 | 129,980.0000 | 42,607,717 | 4.63% | 0.01% |
| Dec. 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | S | Common Stock | 5046 | $80.80 | 136,286.0000 | 42,607,717 | 3.57% | 0.01% |
| Dec. 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | S | Common Stock | 4766 | $81.50 | 128,832.0000 | 42,607,717 | 3.57% | 0.01% |
| Dec. 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | S | Common Stock | 5680 | $80.71 | 133,598.0000 | 42,607,717 | 4.08% | 0.01% |
| Sept. 16, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | G | Common Stock | 2000 | $0.00 | 151,778.0000 | 37,604,538 | 1.30% | 0.01% |
| Sept. 8, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | S | Common Stock | 27116 | $57.00 | 153,778.0000 | 37,604,538 | 14.99% | 0.07% |
| June 13, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | M | Restricted Stock Units | 3350 | $0.00 | 0.0000 | 37,604,538 | 100.00% | 0.01% |
| June 13, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | M | Common Stock | 3350 | $0.00 | 180,894.0000 | 37,604,538 | 1.89% | 0.01% |
| June 12, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | A | Stock Option (right to buy) | 4540 | $0.00 | 4,540.0000 | 37,604,538 | 9999.99% | 0.01% |
| June 12, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | A | Restricted Stock Units | 2954 | $0.00 | 2,954.0000 | 37,604,538 | 9999.99% | 0.01% |
| June 3, 2025 | RxSight, Inc. | $RXST | LINK WILLIAM J PHD | Not found | A | Common Stock | 10752 | $0.00 | 59,103.0000 | 40,490,542 | 22.24% | 0.03% |
| May 23, 2025 | LENSAR, Inc. | $LNSR | LINK WILLIAM J PHD | Not found | A | Common Stock | 7374 | $0.00 | 550,641.0000 | 11,518,000 | 1.36% | 0.06% |
| Aug. 12, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Not found | J | Common Stock | 27116 | $0.00 | 177,544.0000 | 29,383,276 | 18.03% | 0.09% |
| Aug. 12, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Not found | S | Common Stock | 29979 | $26.01 | 182,565.0000 | 29,383,276 | 14.10% | 0.10% |
| Aug. 12, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Not found | S | Common Stock | 5021 | $26.53 | 177,544.0000 | 29,383,276 | 2.75% | 0.02% |
| Aug. 12, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Not found | J | Common Stock | 74892 | $0.00 | 212,544.0000 | 29,383,276 | 26.06% | 0.25% |
| Aug. 12, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Not found | J | Common Stock | 10446 | $0.00 | 177,544.0000 | 29,383,276 | 6.25% | 0.04% |
| June 24, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | M | Restricted Stock Units | 3350 | $0.00 | 0.0000 | 29,383,276 | 100.00% | 0.01% |
| June 24, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | M | Common Stock | 3350 | $0.00 | 139,982.0000 | 29,383,276 | 2.45% | 0.01% |
| June 13, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | A | Restricted Stock Units | 3350 | $0.00 | 3,350.0000 | 29,383,276 | 9999.99% | 0.01% |
| June 13, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 29,383,276 | 9999.99% | 0.02% |
| June 6, 2024 | RxSight, Inc. | $RXST | LINK WILLIAM J PHD | Not found | A | Common Stock | 2554 | $0.00 | 48,351.0000 | 0 | 5.58% | 0.00% |
| May 7, 2024 | LENSAR, Inc. | $LNSR | LINK WILLIAM J PHD | Not found | A | Common Stock | 22000 | $0.00 | 543,267.0000 | 10,971,000 | 4.22% | 0.20% |
| Feb. 1, 2024 | RxSight, Inc. | $RXST | LINK WILLIAM J PHD | Not found | S | Common Stock | 7652 | $50.01 | 48,797.0000 | 0 | 13.56% | 0.00% |
| Feb. 1, 2024 | RxSight, Inc. | $RXST | LINK WILLIAM J PHD | Not found | S | Common Stock | 20598 | $49.54 | 56,449.0000 | 0 | 26.73% | 0.00% |
| Feb. 1, 2024 | RxSight, Inc. | $RXST | LINK WILLIAM J PHD | Not found | G | Common Stock | 3000 | $0.00 | 45,797.0000 | 0 | 6.15% | 0.00% |
| Aug. 17, 2023 | RxSight, Inc. | $RXST | LINK WILLIAM J PHD | Director | J | Common Stock | 21248 | $0.00 | 77,047.0000 | 0 | 38.08% | 0.00% |
| Aug. 17, 2023 | RxSight, Inc. | $RXST | LINK WILLIAM J PHD | Director | J | Common Stock | 694124 | $0.00 | 24,549.0000 | 0 | 96.58% | 0.00% |
| Aug. 17, 2023 | RxSight, Inc. | $RXST | LINK WILLIAM J PHD | Director | J | Common Stock | 2610 | $0.00 | 77,047.0000 | 0 | 3.51% | 0.00% |
| June 22, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 24,619,700 | 9999.99% | 0.02% |
| June 22, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | A | Restricted Stock Units | 3350 | $0.00 | 3,350.0000 | 24,619,700 | 9999.99% | 0.01% |
| June 16, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | M | Common Stock | 2000 | $0.00 | 136,632.0000 | 24,619,700 | 1.49% | 0.01% |
| June 16, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | M | Restricted Stock Units | 2000 | $0.00 | 0.0000 | 24,619,700 | 100.00% | 0.01% |
| June 1, 2023 | RxSight, Inc. | $RXST | LINK WILLIAM J PHD | Director | A | Common Stock | 5731 | $0.00 | 747,313.0000 | 0 | 0.77% | 0.00% |
| May 25, 2023 | LENSAR, Inc. | $LNSR | LINK WILLIAM J PHD | Director | A | Common Stock | 9288 | $0.00 | 521,267.0000 | 0 | 1.81% | 0.00% |
| May 25, 2023 | LENSAR, Inc. | $LNSR | LINK WILLIAM J PHD | Director | A | Stock Option (Right to Buy) | 33175 | $0.00 | 33,175.0000 | 0 | 9999.99% | 0.00% |
| May 11, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | J | Common Stock | 41219 | $0.00 | 244,524.0000 | 24,619,700 | 20.27% | 0.17% |
| May 11, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | J | Common Stock | 215576 | $0.00 | 244,524.0000 | 24,619,700 | 46.85% | 0.88% |
| May 11, 2023 | RxSight, Inc. | $RXST | LINK WILLIAM J PHD | Director | J | Common Stock | 98715 | $0.00 | 741,582.0000 | 0 | 15.36% | 0.00% |
| May 11, 2023 | RxSight, Inc. | $RXST | LINK WILLIAM J PHD | Director | J | Common Stock | 258390 | $0.00 | 47,458.0000 | 0 | 84.48% | 0.00% |
| March 15, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | J | Common Stock | 52194 | $0.00 | 418,881.0000 | 24,619,700 | 14.23% | 0.21% |
| March 15, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | LINK WILLIAM J PHD | Director | J | Common Stock | 215575 | $0.00 | 418,881.0000 | 24,619,700 | 33.98% | 0.88% |